Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The impact of collider bias on genetic prediction in psychotic disorders
    Published on 2025-11-20
    10 months ago
  • Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype
    Published on 2025-11-17
    10 months ago
  • Altered amygdala and striatal responsivity and prediction error encoding of temporal reward dynamics in post-trauma psychopathology
    Published on 2025-11-16
    10 months ago
  • IN MEMORIAM: Nolan R. Williams, MD
    Published on 2025-11-14
    10 months ago
  • Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018–2024
    Published on 2025-11-13
    10 months ago
  • Identifying behavioral and biological predictors of cannabis vapor self-administration in rats
    Published on 2025-11-13
    10 months ago
  • Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity
    Published on 2025-11-12
    10 months ago
« Previous 1 … 39 40 41 42 43 … 143 Next »
Journal of Psychopharmacology
  • The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis
    Published on 2025-02-01
    2 years ago
  • Challenges for switching central nervous system and psychiatric medication products: A review of the literature
    Published on 2025-01-31
    2 years ago
  • Systemic bupropion treatment reduces long-access cocaine self-administration in male and female rats
    Published on 2025-01-30
    2 years ago
  • Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities
    Published on 2025-01-25
    2 years ago
  • Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
    Published on 2025-01-20
    2 years ago
  • A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
    Published on 2025-01-20
    2 years ago
  • Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
    Published on 2025-01-07
    2 years ago
« Previous 1 … 39 40 41 42 43 … 154 Next »
European Neuropsychopharmacology
  • A meta-analysis of data-driven cognitive subgroups in bipolar disorder
    Published on 2024-11-06
    2 years ago
  • Placental epigenetic signatures of maternal distress in glucocorticoid-related genes and newborn outcomes: A study of Spanish primiparous women
    Published on 2024-11-06
    2 years ago
  • Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area
    Published on 2024-11-02
    2 years ago
  • Does 18 Hz deep TMS benefit a different subgroup of depressed patients relative to 10 Hz rTMS? The role of the individual alpha frequency
    Published on 2024-10-12
    2 years ago
  • Towards a consensus roadmap for a new diagnostic framework for mental disorders
    Published on 2024-09-28
    2 years ago
  • Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses
    Published on 2024-09-28
    2 years ago
  • Structural connectivity of dopaminergic pathways in major depressive disorder: An ultra-high resolution 7-Tesla diffusion MRI study
    Published on 2024-09-28
    2 years ago
« Previous 1 … 39 40 41 42 43 … 170 Next »

   Pharma Pub